申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:EP0183191A1
公开(公告)日:1986-06-04
Thienylthiazole compounds of the formula:
and pharmaceutically acceptable acid addition salts thereof,
wherein:
R is amino, guanidino, alkylamino, alkenylamino, unsubstituted or optionally substituted phenylamino or acylamino;
A is amino, alkylamino, cyclic amino, alkanoylamino, a group of the formula:
-NHCO(CH2)x(CH)y(CH2)2=XR3 or - NHCOR5 I R4
wherein each symbol is as defined in claim 1;
Z is hydrogen, halogen; and
m is 0 or 1 to 4, are useful in the treatment of peptic ulcer, acute or chronic gastritis, acute damage of gastric mucous membrane, dimentia and anxiety.
式中的噻吩基噻唑化合物及其药学上可接受的酸加成盐,其中:R 是氨基、胍基、烷基氨基、烯基氨基、未取代或任选取代的苯基氨基或酰基氨基;A 是氨基、烷基氨基、环氨基、烷酰氨基、式中的基团:-NHCO(CH2)x(CH)y(CH2)2=XR3 或 - NHCOR5 I R4,其中每个符号如权利要求 1 所定义;Z 是氢、卤素;m 是 0 或 1 至 4,可用于治疗消化性溃疡、急性或慢性胃炎、胃黏膜急性损伤、痴呆和焦虑症。